Association of Vitamin D Receptor FokI and TaqI Gene Polymorphisms in Pakistani Women with 25(OH)D Levels

Amna Younus^1, , Mariam Faiz² and Abida Yasmeen¹

¹Department of Chemistry, Lahore College For Women University

²Department of Pathology, Institute Of Nuclear Medicine And Oncology Lahore

Cite this paper:
Amna Younus, Mariam Faiz and Abida Yasmeen. Association of Vitamin D Receptor FokI and TaqI Gene Polymorphisms in Pakistani Women with 25(OH)D Levels. Journal of Food and Nutrition Research. 2017; 5(7):475-480. doi: 10.12691/jfnr-5-7-4

Abstract

Vitamin D receptor mediates the effects of calcitriol on gene expression. VDR gene polymorphisms have been linked with specific health outcomes, including increased risk of osteoporosis, cardiovascular disease, diabetes, some cancers (breast and prostate). Gene based studies give exceptional chance to associate molecular insights with epidemiological information and can disclose factual biological effects. The purpose of present study was to evaluate the genotypic distribution of FokI and TaqI polymorphisms of the VDR gene and their association with serum vitamin D levels in healthy Pakistani women by PCR-RFLP technique. Three hundred healthy women between the age of 19-75years; were selected from different areas of Punjab province, Pakistan. Results showed that genotypic frequency for FF, Ff , ff, TT, Tt and tt was 55, 3, 42, 15, 65, and 20% whereas allelic frequency F vs f and T vs t was 56 vs 44% and 47.5vs 52.5% respectively in Pakistani women population. Results of the study concluded that genotypic frequency distribution of FokI and TaqI polymorphisms in Pakistani population varies differently from other populations and both of these SNPs are associated with vitamin D deficiency and insufficiency. The data may provide basis for future clinical and epidemiological studies.

Keywords:
VDR gene polymorphism FokI TaqI healthy women Punjab Pakistan

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Haddad, S. Vitamin-D receptor (VDR) gene polymorphisms (Taq-I & Apa-I) in Syrian healthy population. Meta Gene. 2: 646-650 2014.
[2]	Welsh, J. E., Wietzke, J. A., Zinser, G. M., Byrne, B., Smith, K. and Narvaez, C. J. Vitamin D-3 Receptor as a Target for Breast Cancer Prevention. J. NUTR. 2003: 2425S-2433S. 2003.
[3]	Uitterlinden, A. G., Fang, Y., Van Meurs, J. B, Pols, H .A. and Van Leeuwen J. P. Gene. Genetics and biology of vitamin D receptor polymorphisms. 2338 (2): 143-56. 2004.
[4]	Khan, M. I., Bielecka, Z. F., Najm, M. Z., Bartnik, E., Czarnecki, J. S., Anna M. Czarnecka, A. M. et al. Vitamin D receptor gene polymorphisms in breast and renal cancer: Current state and future approaches (Review). Int. J. Oncol. 44: 349-363. 2014.
[5]	Trump, D., Hershberger, P. and Bernardi, R. Anti-tumor activity of calcitriol: Pre-clinical and clinical studies. J. Steroid Biochem. Mol. Biol. 89: 519-26. 2004.
[6]	Pike, J. W., Meyers, M., Watanuki, M. et al. Perspectives on mechanisms of gene regulation by 1, 25-dihydroxyvitamin D3 and its receptor. J. Steroid Biochem. Mol. Biol. 103: 389-95. 2007.
[7]	Rukin, N. J. and Strange, R. C. What are the frequency, distribution and functional effects of vitamin D receptor polymorphisms as related to cancer risk?. Nutr. Rev. 65: 96-101. 2007.
[8]	Bid, H. K., Mishra, D. K. and Mittal, R. D. Vitamin-D Receptor (VDR) Gene (Fok-I, Taq-I & Apa-I) Polymorphisms in Healthy Individuals from North Indian Population. APJCP. 6. 147-152. 2005.
[9]	McCullough, M. L., Stevens, V. L., Diver, W. R., Feigelson,H.S., Rodriguez, c., Bostick, R. M. et al. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. BCR. 9(1): 1-7. 2007.
[10]	Chen, C., Liu, Q., Zhu, L., Yang, H. and Wei Lu, W. Vitamin D Receptor Gene Polymorphisms on the Risk of Tuberculosis, a Meta-Analysis of 29 Case-Control Studies. PLOS ONE. 8(12): 1-11. 2013.
[11]	Mohammadi, Z., Keshtkar, A., Bakhsh, F. F., Ebrahimi, M., Amoli, M. M., Ghorbani, M., et al. Prevalence of osteoporosis and vitamin D receptor gene polymorphisms (FokI) in an Iranian general population based study (Kurdistan) (IMOS). Med. J. Islam. Repub. Iran 29: 238. 1-7. 2015.
[12]	Younus, A., Faiz, M. and Yasmeen, A. Serum Vitamin D in Women with Pre and Post Menopausal Newly Diagnosed Breast Cancer in Pakistan. JFFNR. 4(12): 828-833. 2016.
[13]	Holick, M. F. and Chen, T. Vitamin D deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr. 87: 1080S-6S. 2008.
[14]	Masood, Z., Mahmood, Q. and Ashraf, K. T. Vitamin D Deficiency–An Emerging Public Health Problem In Pakistan. JUMDC. 1:4-9. 2010.
[15]	Harris, S. S., Eccleshall, T. R., Gross, C. et al. The vitamin D receptor start codon polymorphism (Fok-1) and bone mineral density in premenopausal American Black and White women. J. Bone Miner. Res. 12: 1043-8. 1997.
[16]	Riggs, B. L., Nguyen, T. V., Melton, L. J. et al. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J. Bone Miner. Res. 10: 991-96. 1995.
[17]	Whitfield, G. K., Remus, L .S., Jurutka, P.W., Zitzer, H., Oza, A. K., Dang, H. T. et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol. Cell Endocrinol.177: 145-59. 2001.
[18]	Garnero, P., Borel, O., Sornay-Rendu, E., et al. Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women. J. Bone Miner. Res. 10: 1283-8. 1995.
[19]	Hutchinson, P. E., Osborne, J. E., Lear, J. T., Smith, A. G., Bowers, P. W., Morris, P.N. et al. Vitamin D Receptor Polymorphisms Are Associated with Altered Prognosis in Patients with Malignant Melanoma. Clin. Cancer Res. 6: 498-504. 2000.
[20]	Minamitani, K., Takahashi, Y., Mingawa, M., Yasuda, T. and Niimi, H. Difference in height associated with a Translation Start Site Polymorphism in the Vitamin D Receptor Gene. Pediatr. Res. 4: 628-32. 1998.
[21]	Kung, A.W., Yeung, S. S. and Lau, K. S. Vitamin D receptor gene polymorphisms and peak bone mass in southern Chinese women. Bone. 22: 389-93. 1996.
[22]	Osman, E., Al Anouti, F., El ghazali, G,. Haq A., Mirgani, R., Al Safar, H. Frequency of rs731236 (Taql), rs2228570 (Fok1) of Vitamin-D Receptor (VDR) gene in Emirati healthy population. Meta Gene. 6: 49-52. 2015.
[23]	Khan, M. I., Bielecka, Z. F., Najm, M. Z., Bartnik, E., Czarnecki, J. S., Czarnecka, A. M. Et Al. Vitamin D receptor gene polymorphisms in breast and renal cancer: Current state and future approaches (Review). Int. J. Oncol. 44: 349-63. 2014.
[24]	Bhanushali, A. A., Lajpal, N., Kulkarni, S. S., Chavan, S. S., Bagadi, S. S. and Das, B. R. Frequency of fokI and taqI polymorphism of vitamin D receptor gene in Indian population and its association with 25-hydroxyvitamin D levels. Int. J. Hum. Genet. 15(3): 108-13. 2009.
[25]	Zmuda, J. M., Cauley, J. A. and Ferell RE: Molecular epidemiology of vitamin D receptor gene variants. Epidemiol. Rev. 22: 203-217, 2000.
[26]	Jurutka, P.W., Remus, L.S., Whifield, G. K., Thomson, P. D., Hsieh, J. C., Zitzer, H. et al. The polymorphic N terminus in human vitamin D receptor isoforms influences the transcriptional activity by modulating interaction with transcription factor IIB. Mol. Endocrinol. 14: 401-20. 2000.
[27]	Akhlaque, U., Ayaz, S. B., Akhtar, N., Ahmad, N. Association of bone mineral density and body mass index in a cohort of Pakistanis: Relation to gender, menopause and ethnicity. The Egyptian Rheumatologist. 39: 39–43. 2017.
[28]	Gul, M. S.,Tasneem, S., Khan, S.H.,Iftikhar, T., Gul, N.,Shah, J. Z. Decreased bone mineral density and associated risk factors in hospital visiting people of Islamabad. J Pak Med Assoc. 64(12): S11-14. 2014.
[29]	Duman, B. S., Tanakol, R., Erensoy, N., Oztürk, M., Yilmazer, S. Vitamin D receptor alleles, bone mineral density and turnover in postmenopausal osteoporotic and healthy women. Med Princ Pract. 13(5): 260-6. 2004.